已收录 268921 条政策
 政策提纲
  • 暂无提纲
18 F-FDG PET/CT Showing Rare Mediastinal Growing Teratoma Syndrome Following Chemotherapy
[摘要] Growing teratoma syndrome (GTS) is a condition in which poorly differentiated cells in a mixed-germ cell tumor (GCT) regress after chemotherapy, and the number of well-differentiated components increases. A 60-year-old man had an 8.0 cm mediastinal tumor with strong 18 F-fluorodeoxyglucose (FDG) uptake [maximum standardized uptake value (SUV max ): 9.2], which was diagnosed as a GCT. After chemotherapy, serum alpha fetoprotein, beta-human chorionic gonadotropin, and tumor 18 F-FDG uptake decreased (SUV max : 3.9), but the tumor volume increased. The tumor was completely resected, and pathology confirmed the diagnosis of GTS. 18 F-FDG positron emission tomography after chemotherapy reflects the proliferation of highly differentiated tumor components with poor 18 F-FDG uptake.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 
[关键词] Growing teratoma syndrome;18F-FDG PET;mediastinum;germ cell tumor [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文